Pfizer Inc (PFE)
25.64
+0.17
(+0.67%)
USD |
NYSE |
Feb 13, 16:00
25.62
-0.02
(-0.08%)
After-Hours: 17:35
Pfizer Free Cash Flow: 8.227B for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen Inc | 11.49B |
| Gilead Sciences Inc | 10.83B |
| Regeneron Pharmaceuticals Inc | 3.539B |
| Viking Therapeutics Inc | -74.25M |
| Moderna Inc | -3.956B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 6.714B |
| Cash from Investing (Quarterly) | -2.057B |
| Cash from Financing (Quarterly) | -4.636B |
| Free Cash Flow Per Share (Quarterly) | 1.063 |
| Free Cash Flow to Equity (Quarterly) | 8.123B |
| Free Cash Flow to Firm (Quarterly) | 6.697B |
| Free Cash Flow Yield | 5.63% |